跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Oxaltin
Approved
STANDARD
Oxaltin
Jiangsu Hengrui Medicine Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
65223392bdbcfeb8
Company
Jiangsu Hengrui Medicine Co., Ltd.
Type
Standard
Approval Details
Approval Id
65223392bdbcfeb8
Drug Approval Philippines Name
Oxaltin
Product Name
Oxaltin
Registration Number
DR-XY47591
Brand Name
Oxaltin
Generic Name
Oxaliplatin
Dosage Form
Concentrate Solution for Intravenous Injection
Dosage Strength
5 mg/mL (50 mg/10 mL and 100 mg/20 mL)
Manufacturer
Jiangsu Hengrui Medicine Co., Ltd.
Importer
Phil Pharma wealth, Inc.
Distributor
Phil Pharmawealth, Inc.
Company Detail Path
/organization/jiangsu-hengrui-medicine-co-ltd
Issuance Date
28 December 2022
Expiry Date
09 December 2026
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
65223392bdbcfeb8
Type
Standard
Back to Philippines FDA Approvals
Oxaltin - Philippines FDA Drug Approval Details